Furthermore, GSH disrupted the biofilms of a variety of phenotypes, irrespective of the type or quantity of phenazines produced
Here we conducted five cohort studies to assess the effectiveness of tirzepatide and semaglutide in patients with elevated cardiovascular risk, including obesity and type 2 diabetes, enrolled in insurance programs in the USA between 2018 and 2025
GLP-1 agonists work by stimulating the GLP-1 receptors, which leads to several beneficial effects, particularly in the management of type 2 diabetes and obesity: Increased Insulin Secretion: They enhance the secretion of insulin from the pancreas in response to food intake, helping to lower blood sugar levels
It may also be used in people with a BMI of 27 or higher who have other weight-related medical conditions, such as type 2 diabetes or high blood pressure
Current Psychiatry Reports